Archives biogen-idec

Entry Author Date Location
Biogen R&D Chief Doug Williams Leaves to Run New Cancer Startup 07/10/15 Boston
Xconomy Boston’s Top Stories of Q1 2015: Editor’s Picks 04/01/15 Boston
Stop the Bleeding: Can Gene Therapy Finally Cure Hemophilia? 03/23/15 National
Biogen Drug Shows Early Promise in Slowing Alzheimer’s Decline 03/20/15 Boston
In Mental Health Therapy, Cautious Steps Toward the Pharmacodigital 03/17/15 National
23andMe Pharma? That’s the Plan, Says the Genetic Test Maker 03/12/15 San Francisco
GE Backs Evidation Health to Tackle Digital Health 03/05/15 San Francisco
With Celiac Deal, Celimmune Aims to Give New Life to Old Amgen Drug 03/02/15 New York
Vertex Buys Spine Drug on the QT As Part of Its Post-Hep C Makeover 02/20/15 Boston
East Coast Biotech Roundup: Genzyme, 21st Century Cures, Acorda, & More 02/13/15 Boston
Fannin Spinout Acelerox Aims to Halt Immune Attacks With Nanotech 02/11/15 Texas
With Early Data, Alkermes Plots Quick Jump to Pivotal Study For MS Drug 02/09/15 Boston
East Coast Biotech Roundup: Hamburg, Merck, Annovation, WaVe & More 02/09/15 Boston
Find Out “What’s Hot in Boston Biotech” on April 8 02/05/15 Boston
Built for a Deal, Annovation Rewards Backers With Medicines Co. Buyout 02/04/15 Boston
East Coast Biotech Roundup: Yumanity, Biogen, Blizzards, & More 01/30/15 Boston
West Coast Biotech Roundup: Qualcomm, Google X, Mapp, Onyx, & More 01/29/15 San Francisco
Biogen Places Gene Therapy Bet in Crowded Hemophilia Space 01/29/15 Boston
Speaking LINGO, Biogen R&D Chief Wants to Push Nerve Repair Boundary 01/26/15 Boston
From Yeast, Yumanity Looks to Give Rise to Critical Neuro Drugs 01/26/15 Boston
Dallas’ AveXis Gets $10M to Bring Gene Therapy to Rare Spinal Disorder 01/20/15 Texas
East Coast Biotech Roundup: Foundation, Biogen, Moderna, & Lots More 01/16/15 Boston
Attacking Parkinson’s Via Gaucher Link, LTI Ready for Its Series A 01/15/15 Boston
East Coast Biotech Roundup: Pre-J.P. Morgan Preening Edition 01/09/15 Boston
East Coast Biotech Roundup: Yumanity, Padlock, CAR-T Fever, & More 12/19/14 Boston
Déjà Vu For Gilman as New Immunology Startup, Padlock, Gets $23M 12/18/14 Boston
Déjà Vu? Elan Alumni Start Antibody Firm to Fight Neurodegeneration 12/15/14 San Francisco
Pioneer’s Lament: Lack of Checkpoint Immunotherapy For Blood Cancer 12/08/14 National
East Coast Biotech Roundup: Unum, RaNA, Maxwell, Biogen, & More 12/05/14 Boston
After Unlikely Idenix Sale, Renaud Jumps to RaNA to Outfox Junk DNA 12/01/14 Boston
Page 1 of 19 next page »